Successful dual antiviral therapy with remdesivir and ensitrelvir in a case of prolonged COVID-19 following B-cell depleting immunotherapy for malignant lymphoma

Prolonged COVID-19 following B-cell depleting immunotherapy for malignant lymphoma is characterized by repeated cycles of remission followed by symptom recurrence, persistent detection of SARS-CoV-2, and profound humoral immunodeficiency. To the best of our knowledge, the present report is the first...

Descripción completa

Detalles Bibliográficos
Autores principales: Jung, Seowoong, Yagi, Yu, Fukushima, Kazuaki, Nishikawa, Yukari, Tanaka, Masaru, Kobayashi, Taiichiro, Yajima, Keishiro, Ajisawa, Atsushi, Imamura, Akifumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10482734/
https://www.ncbi.nlm.nih.gov/pubmed/37693339
http://dx.doi.org/10.1016/j.idcr.2023.e01890

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10482734/
https://www.ncbi.nlm.nih.gov/pubmed/37693339
http://dx.doi.org/10.1016/j.idcr.2023.e01890

Ejemplares similares